INFLABLOC PHARMACEUTICALS INC has a total of 13 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), Australia and Republic of Korea. Its main competitors in its focus markets pharmaceuticals are NUON THERAPEUTICS INC, NATURAL COMPOUNDS LTD and TOLTEC PHARMACEUTICALS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Australia | 2 | |
#3 | Republic of Korea | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Canada | 1 | |
#7 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Gebhard John R | 9 |
#2 | Weinshenker Ned M | 7 |
#3 | Araneo Barbara A | 7 |
#4 | Patel Dinesh | 5 |
#5 | Vollmer David | 4 |
#6 | Daugherty Claire | 4 |
#7 | West Frederick G | 3 |
#8 | Li Weiping | 3 |
#9 | Gebhard John | 1 |
#10 | David Vollmer | 1 |
Publication | Filing date | Title |
---|---|---|
AU2008229041A1 | Cobalamin taxane bioconjugates | |
US2006004076A1 | Co-administration of dehydroepiandrosterone (DHEA) congener with pharmaceutically active agents for treating inflammation | |
AU2003297216A1 | Dehydroepiandrosterone (dhea) congeners for prevention and/or treatment of ulcers | |
US7232805B2 | Cobalamin conjugates for anti-tumor therapy |